Sippican Capital Advisors
- SEC CIK
- 0001557406
- Latest filing
- Jul 22, 2026
TAK holding history
Takeda Pharmaceutical Co Ltd in every 13F filed by Sippican Capital Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TAK overviewAll 13F holders of TAKFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −10,684−100.0% | Sold out | Holders |
| Q3 2023 | 10,684 | $165.3K | 0.2% | −70,115−86.8% | Reduced | Holders |
| Q2 2023 | 80,799 | $1.27M | 1.2% | −1,436−1.7% | Reduced | Holders |
| Q1 2023 | 82,235 | $1.36M | 1.3% | 00.0% | Unchanged | Holders |
| Q4 2022 | 82,235 | $1.28M | 1.2% | −5,225−6.0% | Reduced | Holders |
| Q3 2022 | 87,460 | $1.13M | 1.2% | +1,415+1.6% | Added | Holders |
| Q2 2022 | 86,045 | $1.21M | 1.2% | +5,555+6.9% | Added | Holders |
| Q1 2022 | 80,490 | $1.15M | 1.0% | +10,940+15.7% | Added | Holders |
| Q4 2021 | 69,550 | $948.0K | 0.8% | +26,230+60.5% | Added | Holders |
| Q3 2021 | 43,320 | $710.0K | 0.6% | +33,110+324.3% | Added | Holders |
| Q2 2021 | 10,210 | $172.0K | 0.1% | +10,210 | New | Holders |